Grabar S, Costagliola D. Epidemiology of Kaposi’s Sarcoma. Cancers (Basel). 2021;13(22):5692. https://doi.org/10.3390/cancers13225692.

Article  CAS  PubMed  Google Scholar 

Cianfrocca M, Lee S, Von Roenn J, et al. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. 2010;116(16):3969–77. https://doi.org/10.1002/cncr.25362.

Article  PubMed  Google Scholar 

Armstrong AW, Lam KH, Chase EP. Epidemiology of classic and AIDS-related Kaposi’s sarcoma in the USA: incidence, survival, and geographical distribution from 1975 to 2005. Epidemiol Infect. 2013;141(1):200–6. https://doi.org/10.1017/S0950268812000325.

Article  CAS  PubMed  Google Scholar 

Lebbe C, Garbe C, Stratigos AJ, et al. Diagnosis and treatment of Kaposi’s sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC). Eur J Cancer. 2019;114:117–27. https://doi.org/10.1016/j.ejca.2018.12.036.

Article  CAS  PubMed  Google Scholar 

Cesarman E, Damania B, Krown SE, et al. Kaposi sarcoma. Nat Rev Dis Primers. 2019;5(1):9. https://doi.org/10.1038/s41572-019-0060-9.

Article  PubMed  PubMed Central  Google Scholar 

Freeman EE, McMahon DE, Laker-Oketta M. Time to address disparities in the standard of care for Kaposi sarcoma. Lancet. 2020;395(10231):1169–70. https://doi.org/10.1016/s0140-6736(20)30473-6.

Article  PubMed  Google Scholar 

Herce ME, Kalanga N, Wroe EB, et al. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi. J Int AIDS Soc. 2015;18(1):19929. https://doi.org/10.7448/IAS.18.1.19929.

Article  PubMed  PubMed Central  Google Scholar 

Sengayi MM, Kielkowski D, Egger M, et al. Survival of patients with Kaposi’s sarcoma in the South African antiretroviral treatment era: a retrospective cohort study. S Afr Med J. 2017;107:10.

Article  Google Scholar 

Chow JY, Konda KA, Borquez A, Caballero P, Silva-Santisteban A, Klausner JD, et al. Peru’s HIV care continuum among men who have sex with men and transgender women: opportunities to optimize treatment and prevention. Int J STD AIDS. 2016;27(12):1039–48.

Article  PubMed  PubMed Central  Google Scholar 

Informe Nacional Sobre Los Progresos Realizados en el País: Peru. 2014. Lima, Peru: United Nations General Assembly Special Session (UNGASS) on HIV/AIDS; 2014. Accessed 12 Oct 2023. p. 175. 2012-December 2013.

Estudio de Vigilancia Epidemiológica de ITS y VIH en Hombres que Tienen Sexo con Hombres Comparando las Metodologías de Reclutamiento: Muestreo por Conveniencia, Muestreo por Tiempo y Espacio y el Muestreo Dirigido por Participantes. Lima, Peru: Coordinadora Nacional Multisectorial en Salud, Fondo Mundial de Lucha Contra el Sida, la Tuberculosis y la Malaria, CARE-Peru; 2011.

Tattsbridge J, Wiskin C, de Wildt G, Clavé Llavall A, Ramal-Asayag C. HIV understanding, experiences and perceptions of HIV-positive men who have sex with men in Amazonian Peru: a qualitative study. BMC Public Health. 2020;20(1):728.

Article  PubMed  PubMed Central  Google Scholar 

Cousins S. A complex epidemic prevents Peru reaching HIV goals. Lancet HIV. 2019;6(11):e733–4.

Article  PubMed  Google Scholar 

Ministerio de Salud. Un paso adelante en la lucha contra el SIDA: Los primeros dos años de acceso universal al tratamiento antiretroviral en el Perú. Lima: MINSA, 2006.

Krown SE, Metroka C, Wernz JC. Kaposi’s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1989;7(9):1201–7. https://doi.org/10.1200/jco.1989.7.9.1201.

Article  CAS  PubMed  Google Scholar 

Ministerio de Salud. NTS N° 097 - Norma Técnica de Salud de Atención Integral del Adulto con Infección por el Virus de la Inmunodeficiencia Humana (VIH). Lima: El Peruano; 2014.

Spano J-P, Salhi Y, Costagliola D, et al. Factors predictive of disease progression and death in AIDS-related Kaposi’s sarcoma. HIV Med. 2000;1(4):232–7. https://doi.org/10.1046/j.1468-1293.2000.00034.x.

Article  CAS  PubMed  Google Scholar 

Laresche C, Fournier E, Dupond AS, et al. Kaposi’s sarcoma: a population-based cancer registry descriptive study of 57 consecutive cases diagnosed between 1977 and 2009. Int J Dermatol. 2014;53(12):e549–54. https://doi.org/10.1111/ijd.12453.

Article  PubMed  Google Scholar 

Oyucu Orhan S, Bilgehan Sahin A, Cubukcu E, et al. Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: a single-center retrospective real-world data. Biomol Biomed. 2021;21(6):746–51. https://doi.org/10.17305/bjbms.2020.5329.

Article  CAS  Google Scholar 

Mohanna S, Maco V, Bravo F, et al. Epidemiology and clinical characteristics of classic Kaposi’s sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int J Infect Dis. 2005;9(5):239–50. https://doi.org/10.1016/j.ijid.2005.02.004.

Article  PubMed  Google Scholar 

Pires CAA, Noronha MAN, Monteiro JCMS, et al. Kaposi’s sarcoma in persons living with HIV/AIDS: a case series in a tertiary referral hospital*. An Bras Dermatol. 2018;93(4):524–8. https://doi.org/10.1590/abd1806-4841.20186978.

Article  PubMed  PubMed Central  Google Scholar 

Cuellar LE, Meza K, Holguín AM, et al. Clinicopathological features and mortality in patients with Kaposi sarcoma and HIV: a retrospective analysis of a thirty-year study from a peruvian oncologic center. JCO Global Oncol. 2022;8: e2100379. https://doi.org/10.1200/go.21.00379.

Article  Google Scholar 

Lima CT, Araújo PSR, Teixeira HM, et al. Clinical and laboratory characteristics, staging, and outcomes of individuals with AIDS-associated Kaposi’s sarcoma at an university hospital. An Bras Dermatol. 2017;92(2):172–6. https://doi.org/10.1590/abd1806-4841.20175377.

Article  PubMed  PubMed Central  Google Scholar 

Rohner E, Kasaro M, Msadabwe-Chikuni SC, et al. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison. Pan Afr Med J. 2017;28:261. https://doi.org/10.11604/pamj.2017.28.261.11300.

Article  PubMed  PubMed Central  Google Scholar 

Bower M, Collins S, Cottrill C, et al. British HIV Association guidelines for HIV-associated malignancies 2008. HIV Med. 2008;9(6):336–88. https://doi.org/10.1111/j.1468-1293.2008.00608.x.

Article  CAS  PubMed  Google Scholar 

Group W, Bower M, Palfreeman A, et al. British HIV Association guidelines for HIV-associated malignancies 2014. HIV Med. 2014;15(S2):1–92. https://doi.org/10.1111/hiv.12136.

Article  CAS  Google Scholar 

Krown SE, Moser CB, MacPhail P, et al. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial. Lancet. 2020;395(10231):1195–207. https://doi.org/10.1016/S0140-6736(19)33222-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sebastian JL, Munoz M, Palacios E, Espiritu B, Mestanza L, Chalco K, et al. Scaling up HIV treatment in Peru: applying lessons from DOTS-plus. J Int Assoc Phys AIDS Care (Chicago, Ill: 2002). 2006;5(4):137–42.

Google Scholar 

Brambilla L, Labianca R, Boneschi V, et al. Mediterranean Kaposi’s sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine. Cancer. 1994;74(10):2873–8. https://doi.org/10.1002/1097-0142(19941115)74:10%3c2873::aid-cncr2820741021%3e3.0.co;2-1.

Article  CAS  PubMed  Google Scholar 

Delyon J, Biard L, Renaud M, et al. PD-1 blockade with pembrolizumab in classic or endemic Kaposi’s sarcoma: a multicentre, single-arm, phase 2 study. Lancet Oncol. 2022;23(4):491–500. https://doi.org/10.1016/s1470-2045(22)00097-3.

Article  CAS  PubMed  Google Scholar 

Di Lorenzo G, Kreuter A, Di Trolio R, et al. Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi’s sarcoma: a multicenter study. J Invest Dermatol. 2008;128(6):1578–80. https://doi.org/10.1038/sj.jid.5701215.

Article  CAS  PubMed  Google Scholar 

Benajiba L, Lambert J, La Selva R, et al. Systemic treatment initiation in classical and endemic Kaposi’s sarcoma: risk factors and global multi-state modelling in a monocentric cohort study. Cancers (Basel). 2021;13:11. https://doi.org/10.3390/cancers13112519.

Article  Google Scholar 

Ministerio de Salud. Evaluación de Medicamentos para la Elaboración de la Lista Complementaria de Medicamentos para el Tratamiento de Enfermedades Neoplasicas al Petitorio Nacional Unico de Medicamentos Esenciales. Lima: DIGEMID; 2008.

Royse KE, El Chaer F, Amirian ES, et al. Disparities in Kaposi sarcoma incidence and survival in the United States: 2000–2013. PLoS ONE. 2017;12(8):e0182750. https://doi.org/10.1371/journal.pone.0182750.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bower M, Dalla Pria A, Coyle C, et al. Prospective stage-stratified approach to AIDS-related Kaposi’s sarcoma. J Clin Oncol. 2014;32(5):409–14. https://doi.org/10.1200/jco.2013.51.6757.

Article  PubMed  Google Scholar